
1. Technology overview
TAIMedimg is the medical imaging brand of Taiwan AI Labs. The company provides validated AI medical imaging models for clinics and hospitals and a federated learning platform for medical professionals and AI experts. Its site names a Kaohsiung R&D Center and a Kaohsiung office opened in June 2024, and lists a Taiwan FDA medical device license, ISO 13485 and Medical Devices GMP certification.
DeepMets is a TFDA-approved AI model (license MOHW-MD-No. 007653) for auto-contouring tumors on brain MRI, developed with Taipei Veterans General Hospital. DeepBrai assists in interpreting brain images, and DeepContour auto-contours organs. The FedMed platform supports image and data interpretation, report drafting with Fed-GPT, lesion localization, progression tracking, automated federated learning and smart labeling.
2. Highlighted features & specifications
- DeepMets: TFDA-approved AI model for auto-contouring brain tumors on MRI.
- DeepBrai: assistant for interpreting brain images, with a stroke example.
- DeepContour: AI model for auto-contouring organs with generative AI for therapy planning.
- Fed-GPT: supports report drafting.
- Federated learning: automated federated learning across hospitals.
- Smart labeling: tools to label lesions and track progression for follow-up.
3. Potential application
Vietnamese oncology and neurosurgery centers can use auto-contouring to prepare radiosurgery plans for brain metastases. Hospital networks can train shared AI models without exchanging patient images. Research hospitals can use smart labeling to build annotated datasets.
4. Benefits
Supports brain tumor contouring on MRI with a TFDA-approved model, reducing manual contouring work. Federated learning lets hospitals train AI on local data without moving it out. Report drafting and progression tracking help follow-up and trial evaluation. A company news item states DeepMets secured official approval in Vietnam in 2023.
5. Market trends & opportunities
Radiotherapy planning and brain tumor follow-up consume large clinician time, and privacy rules push hospitals toward federated learning. Taiwan AI Labs reports expansion of DeepMets into Southeast Asia and an approval in Vietnam, where oncology centers are expanding radiotherapy capacity.
6. Other information
Associated with Taiwan AI Labs; Kaohsiung R&D Center and office opened 2024-06. Site lists Taiwan FDA license, ISO 13485 and GMP. MOUs reported with Samsung Medical Center. Founding year and a legal address are not stated on the pages fetched.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































